Beijing Chunlizhengda Medical Instruments Co., Ltd. (HKG:1858)

HKG:1858 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	1,053	805.22	1,207	1,199	1,107	937.56
Other Revenue	0.64	0.64	1.04	2.58	0.91	0.13
Revenue	1,054	805.86	1,209	1,202	1,108	937.69
Revenue Growth (YoY)	13.95%	-33.32%	0.58%	8.43%	18.18%	9.63%
Cost of Revenue	380.78	289.37	353.34	301.53	264.11	257.09
Gross Profit	672.89	516.49	855.18	900.08	844.03	680.6
Selling, General & Admin	275.51	285.54	427.61	430.31	372.73	272.23
Research & Development	119.89	133.1	157.45	162.34	104.84	72.6
Other Operating Expenses	3.43	1.62	4.41	13.33	9.2	9.45
Operating Expenses	409.69	424.53	593.88	618.73	499.58	360.68
Operating Income	263.2	91.96	261.3	281.35	344.44	319.92
Interest Expense	-0.03	-0.04	-0.09	-0.05	-	-
Interest & Investment Income	23.08	27.29	26.47	23.6	10.76	6.27
Currency Exchange Gain (Loss)	1.78	1.78	2.48	3.57	-0.86	-4.49
Other Non Operating Income (Expenses)	-0.69	-0.9	-0.18	-4.27	-4.22	0.18
EBT Excluding Unusual Items	287.34	120.09	289.99	304.2	350.12	321.88
Impairment of Goodwill	-13.36	-13.36	-	-	-	-
Gain (Loss) on Sale of Investments	10.43	9.43	9.61	9.49	-	-
Gain (Loss) on Sale of Assets	0	0.04	0	0.03	0.01	-0.19
Asset Writedown	-22.65	-	-	-	-	-
Other Unusual Items	15.46	15.39	6.3	23.16	17.24	8.16
Pretax Income	277.22	131.6	305.91	336.88	367.38	329.85
Income Tax Expense	21.96	6.94	28.09	29.16	45.02	46.47
Earnings From Continuing Operations	255.27	124.66	277.82	307.72	322.36	283.37
Minority Interest in Earnings	0.1	0.33	0.01	-	-	-
Net Income	255.37	124.99	277.82	307.72	322.36	283.37
Net Income to Common	255.37	124.99	277.82	307.72	322.36	283.37
Net Income Growth	61.27%	-55.01%	-9.71%	-4.54%	13.76%	19.69%
Shares Outstanding (Basic)	379	379	386	385	347	346
Shares Outstanding (Diluted)	379	379	386	385	347	346
Shares Change (YoY)	-1.27%	-1.84%	0.32%	10.97%	0.30%	-0.75%
EPS (Basic)	0.67	0.33	0.72	0.80	0.93	0.82
EPS (Diluted)	0.67	0.33	0.72	0.80	0.93	0.82
EPS Growth	63.34%	-54.17%	-10.00%	-13.98%	13.41%	20.59%
Free Cash Flow	124.5	-51.07	478.47	16.1	-34.62	236.68
Free Cash Flow Per Share	0.33	-0.14	1.24	0.04	-0.10	0.69
Dividend Per Share	0.259	0.132	0.362	0.313	0.130	-
Dividend Growth	-41.80%	-63.54%	15.65%	140.77%	-	-
Gross Margin	63.86%	64.09%	70.76%	74.91%	76.17%	72.58%
Operating Margin	24.98%	11.41%	21.62%	23.41%	31.08%	34.12%
Profit Margin	24.24%	15.51%	22.99%	25.61%	29.09%	30.22%
Free Cash Flow Margin	11.82%	-6.34%	39.59%	1.34%	-3.12%	25.24%
EBITDA	301.98	128.37	294.55	309.48	360.99	334.87
EBITDA Margin	28.66%	15.93%	24.37%	25.75%	32.58%	35.71%
D&A For EBITDA	38.78	36.41	33.25	28.13	16.55	14.95
EBIT	263.2	91.96	261.3	281.35	344.44	319.92
EBIT Margin	24.98%	11.41%	21.62%	23.41%	31.08%	34.12%
Effective Tax Rate	7.92%	5.27%	9.18%	8.66%	12.25%	14.09%
Revenue as Reported	1,054	805.86	1,209	1,202	1,108	937.69

Source: S&P Global Market Intelligence. Standard template. Financial Sources.